{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:02:52Z","timestamp":1790517772361,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>With current immunosuppressive regimens, BK polyomavirus-associated nephropathy (BKPyVAN) is still a matter of concern. Stratification of patients at risk for allograft loss is of uttermost importance to guide treatment choice and assess prognosis. In 2018, the Banff working group proposed a classification scheme for the prognosis of BKPyVAN, but external application on independent cohorts is yet to be performed. We investigated how the 2018 Banff classification would perform in a multicenter cohort comprising 50 cases of biopsy-proven BKPyVAN compared to previously published classification systems.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We analyzed consecutive BKPyVAN cases from two Dutch university hospitals between 2002 and 2013, retrieved clinical data, and scored all biopsies according to the Banff 2018 classification, and as a comparison, 4 previously proposed BKPyVAN classification systems. We used estimated glomerular filtration rate trajectories and death-censored graft survival as primary endpoints.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The 2018 Banff classification did not associate with estimated glomerular filtration rate decline or graft failure and performed only slightly better than the 4 previously proposed classifiers. Anti-human leukocyte antigen donor-specific antibodies (DSAs), especially in combination with ongoing biopsy-proven BKPyVAN on follow-up, did correlate with graft function and survival. Patients who were DSA+\/BKPyVAN+ on follow-up had more inflammation at the baseline biopsy, which by itself was not associated with graft outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Neither the 2018 Banff BKPyVAN classification nor previously published stratification systems could be applied to our multicenter patient cohort. Our data suggest that there might be a prognostic value for follow-up biopsies and DSA measurements to improve risk stratification after BKPyVAN, although prospective multicenter efforts with protocol measurements are needed to confirm this.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002712","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T03:14:08Z","timestamp":1553483648000},"page":"2692-2700","source":"Crossref","is-referenced-by-count":18,"title":["A Multicenter Application of the 2018 Banff Classification for BK Polyomavirus-associated Nephropathy in Renal Transplantation"],"prefix":"10.1097","volume":"103","author":[{"given":"Yassine","family":"Bouatou","sequence":"first","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam Cardiovascular Sciences (ACS), Meibergdreef 9, Amsterdam, The Netherlands."},{"name":"Department of Nephrology, Geneva University Hospitals, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri Q.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris J.T.H.","family":"Roelofs","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam Cardiovascular Sciences (ACS), Meibergdreef 9, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike J.","family":"Bemelman","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Renal Transplant Unit, Amsterdam Infection & Immunity Institute (AI&II), Meibergdreef 9, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Michielsen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Goldschmeding","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kers","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam Cardiovascular Sciences (ACS), Meibergdreef 9, Amsterdam, The Netherlands."},{"name":"Center for Analytical Sciences Amsterdam (CASA) - Biomolecular Systems Analytics, Van \u2018t Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, The Netherlands."},{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Florquin","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam Infection & Immunity Institute (AI&II), Amsterdam Cardiovascular Sciences (ACS), Meibergdreef 9, Amsterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Pt 7","key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/vir.0.020115-0","article-title":"Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.","volume":"91","author":"Antonsson","year":"2010","journal-title":"J Gen Virol"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors.","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","article-title":"Clinical course of polyoma virus nephropathy in 67 renal transplant patients.","volume":"13","author":"Ramos","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-6143.2002.020106.x","article-title":"Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation.","volume":"2","author":"Hirsch","year":"2002","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/TP.0000000000000183","article-title":"The histology of kidney transplant failure: a long-term follow-up study.","volume":"98","author":"Naesens","year":"2014","journal-title":"Transplantation"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrneph.2011.59","article-title":"BK polyomavirus infection and nephropathy: the virus-immune system interplay.","volume":"7","author":"Babel","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"5 Pt 1","key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2006.01296.x","article-title":"Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).","volume":"6","author":"Wadei","year":"2006","journal-title":"Am J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOT.0000000000000192","article-title":"Polyomaviruses and disease: is there more to know than viremia and viruria?","volume":"20","author":"Nickeleit","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2014010119","article-title":"Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies.","volume":"26","author":"Sawinski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/ajt.12794","article-title":"Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.","volume":"14","author":"Adam","year":"2014","journal-title":"Am J Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1681\/ASN.2017050477","article-title":"The banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations.","volume":"29","author":"Nickeleit","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the banff classification of renal allograft pathology.","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201809 meeting report: antibody mediated graft deterioration and implementation of banff working groups.","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1046\/j.1600-6143.2004.00603.x","article-title":"Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load.","volume":"4","author":"Drachenberg","year":"2004","journal-title":"Am J Transplant"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation.","volume":"13(Suppl 4)","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/TP.0b013e318288caa6","article-title":"MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients.","volume":"95","author":"Masson","year":"2013","journal-title":"Transplantation"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1600-6143.2001.10414.x","article-title":"Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology.","volume":"1","author":"Drachenberg","year":"2001","journal-title":"Am J Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations.","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1600-6143.2012.03993.x","article-title":"The banff 2009 working proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.","volume":"12","author":"Masutani","year":"2012","journal-title":"Am J Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1111\/ajt.13911","article-title":"Antigen-specificity of T cell infiltrates in biopsies with T cell-mediated rejection and BK polyomavirus viremia: analysis by next generation sequencing.","volume":"16","author":"Zeng","year":"2016","journal-title":"Am J Transplant"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/ajt.14292","article-title":"BK virus nephropathy: histological evolution by sequential pathology.","volume":"17","author":"Nankivell","year":"2017","journal-title":"Am J Transplant"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/ajt.14314","article-title":"Histological evolution of BK virus-associated nephropathy: importance of integrating clinical and pathological findings.","volume":"17","author":"Drachenberg","year":"2017","journal-title":"Am J Transplant"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/ajt.14358","article-title":"BK virus nephropathy revisited.","volume":"17","author":"Mengel","year":"2017","journal-title":"Am J Transplant"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/tid.12467","article-title":"Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.","volume":"17","author":"Dieplinger","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2017070749","article-title":"Dynamic prognostic score to predict kidney allograft survival in patients with antibody-mediated rejection.","volume":"29","author":"Viglietti","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R28-20231002","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15299","article-title":"Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.","author":"Bouatou","year":"2019","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:17:26Z","timestamp":1696223846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002712","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}